Brief Report: Preventing Infusion-related Reactions With Intravenous Amivantamab: Results From SKIPPirr, a Phase 2 Study.
Spira AI, Paz-Ares L, Han JY, Shih JY, Mascaux C, Roy UB, Zugazagoitia J, Kim YJ, Chiu CH, Kim SW, Nadal E, Gil-Bazo I, Murphy SP, Anderson BG, Xia Y, Wang G, Bauml JM, Chioda M, Simoes J, Mahadevia PJ, Lopes G.
Spira AI, et al. Among authors: kim yj.
J Thorac Oncol. 2025 Jan 24:S1556-0864(25)00051-6. doi: 10.1016/j.jtho.2025.01.018. Online ahead of print.
J Thorac Oncol. 2025.
PMID: 39864547